The Australian Patent Office has granted the company a patent that contains formulation and method claims to a pharmaceutical formulation comprising a macromolecular pharmaceutical agent in mixed micellar form, and metered dose device containing said formulation, for buccal administration.
Generex currently holds an aggregate of 128 patents worldwide and has an aggregate of 134 patent applications pending in various jurisdictions.
Rose Perri, COO of Generex, said: “We are pleased to include this latest patent to our expanding portfolio. While we continue to move forward with the regulatory process in major markets, we continue to work on patent submissions for other jurisdictions.”